third party pharma manufacturing Baddi

Price 10000.0 INR/ Unit

Get a Price/Quote

MOQ : 100 Units

About third party pharma manufacturing Baddi

Monark Biocare is one of Indias leading pharmaceutical companies, offering reliable and high-quality third-party manufacturing services to clients across the Baddi. With our modern production facilities, experienced team, and WHO-GMP certified units, we ensure that every product manufactured under our name meets global quality standards and delivers proven therapeutic results.

Tell us about your requirement

Price:

Quantity

Select Unit

50
100
200
250
500
1000+

Additional detail

Mobile number

More Products in Analgesic & Anti-inflammatory Drugs - Nsaids Category

Vancomycin Hydrochloride 1000 MG For Intravenous Infusion IP

Price 502.37 INR / Vial

Minimum Order Quantity : 100

Ingredients : Vancomycin Hydrochloride 1000 mg for Intravenous Infusion IP is a sterile lyophilized powder vial containing 1000 mg vancomycin base (as hydrochloride) for reconstitution and IV infusion only. It inhibits bacterial cell wall synthesis by binding DAlaDAla terminus, treating serious Grampositive infections including MRSA bacteremia, endocarditis, complicated skin/soft tissue infections, pneumonia, bone/joint infections, and C. difficile colitis when oral therapy fails.

Life Span : 24 month

Salt Composition : Vancomycin Hydrochloride 1000 MG For Intravenous Infusion IP

Get a Price/Quote

Metformin (SR) 500MG + Pioglitazone HCL 15MG + Glimepiride 2MG Bilayered Tablet

Price 1368.75 INR / Number

Minimum Order Quantity : 100

Ingredients : Metformin (SR) 500 mg + Pioglitazone HCl 15 mg + Glimepiride 2 mg Bilayered Tablet combines sustainedrelease metformin (hepatic glucose suppression), pioglitazone (PPAR agonist improving insulin sensitivity/adipocyte differentiation), and glimepiride (sulfonylurea stimulating insulin secretion) for comprehensive type 2 diabetes management. Triple therapy targets insulin resistance, betacell dysfunction, and hepatic gluconeogenesis, achieving HbA1c reductions of 2.22.8% in patients uncontrolled on dual therapy; pioglitazone provides additional benefits in dyslipidemia (TG 15%, HDL 10%) and atherosclerosis regression. Adults: 1 tablet once daily with meals; side effects include hypoglycemia (1520%), weight gain/edema (pioglitazone), GI upset (less with SR), HF risk (monitor NYHA Class I/II only); contraindicated in DKA, eGFR<30, bladder cancer history; check LFTs, echo periodically.

Life Span : 24 Month

Salt Composition : Metformin (SR) 500MG + Pioglitazone HCL 15MG + Glimepiride 2MG Bilayered Tablet

Get a Price/Quote